Filing metadata

Accession number
0001600620-25-000110
Form type
Form 4
Filer
Aurinia Pharmaceuticals Inc.
CIK
CIK 1600620
Filed
Nov 24, 2025
Reporting period
Nov 21, 2025
Description
Insider transaction

Explore SEC Filings Hub